Molecular Partners AG (MOLN) Q2 2024 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning and welcome to the Molecular Partners fourth quarter and full year 2024 results call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing star then zero on your telephone keypad. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on your telephone keypad. To withdraw your question, please press star then two. please note this event is being recorded. I would now like to turn the conference over to Seth Lewis, Senior Vice President, Investor Relations and Strategy. Please go ahead. Thanks, Drew. And welcome, everybody, to the Molecular Partners year-end results in the 2024 highlights call. My name is Seth Lewis, and I'm joined today by members of our senior leadership team, including Patrick Anstrutz, Chief Executive Officer, Robert Hendricks, SVP of Finance, Philippe Lejeune, Chief Medical Officer, and Michael Stumpf, Executive Vice President of Projects and Head of the DLL3 Radio Program. The team will make some prepared remarks, and then we will open the call for your questions. If you haven't had a chance to see the press release issued yesterday after market close, you can find it on our website, www.molecularpartners.com, where you can also access a copy of today's presentation. Today's fault is being recorded and will be available for replay. Before we begin, I'd like to remind you that management will be making forward-looking statements about the future development of certain programs. These statements reflect the current estimates in Molecular Partners and are subject to change. For the most up-to-date information, please visit our website, www.molecularpartners.com. With that, I'll turn the call over to ...